ASTELLAS PHARMA, INC. (ALPMF)
Clinical trial NCT05404139 updates: 1. completion date: 2026-03-01 → 2031-02-01 2. primary completion date: 2026-03-01 → 2031-02-01
Clinical trial NCT05404139 updates: 1. completion date: 2026-03-01 → 2031-02-01 2. primary completion date: 2026-03-01 → 2031-02-01
📉 **NEGATIVE** • Medium confidence analysis (62%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical